Jay R. Campbell

Director/Board Member at Update Pharma, Inc.

Health Technology

Consumer Services

Distribution Services

Profile

Jay R.
Campbell is currently a Director at Update Pharma, Inc. He previously worked as a Senior Development-Business Development at Kolltan Pharmaceuticals, Inc. and as a Chief Business Officer & VP-Investor Relations at Immutep Ltd.
He completed his undergraduate degree at Bucknell University.

Jay R. Campbell active positions

Companies	Position	Start
Update Pharma, Inc. Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013.	Director/Board Member	-

All active positions of Jay R. Campbell

Former positions of Jay R. Campbell

Companies	Position	End
Kolltan Pharmaceuticals, Inc. Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.	Corporate Officer/Principal	-
IMMUTEP LIMITED	Investor Relations Contact	-

See the detail of Jay R. Campbell's experience

Training of Jay R. Campbell

Bucknell University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jay R. Campbell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
IMMUTEP LIMITED	Health Technology

Private companies	2
Kolltan Pharmaceuticals, Inc. Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.	Health Technology
Update Pharma, Inc. Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013.	Distribution Services